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The mammalian brain matures gradually in a highly region
speciﬁc manner. At particular developmental stages, brain
cells differentiate and are integrated in complex functional
networks. The degree of cellular differentiation (e.g. den-
dritic and axonal aborization and myelination) at any given
developmental time point is reﬂected in regional alterations
of the neurochemical proﬁle as reported in the rat brain (Tka´cˇ
et al. 2003). Thus, metabolite composition and concentration
changes across time allow us to make inferences about the
degree of regional development. There is shared consensus
that psychiatric disorders including schizophrenia (Tsuang
2000), autism (Keller and Persico 2003) and attention deﬁcit/
hyperactivity disorder (for review see Curatolo et al. 2009)
result from interactions between genetic and environmental
risk factors during neurodevelopment. For a better under-
standing of these disorders, it is crucial to characterize the
aberrant developmental processes and to pinpoint sensitive
periods during which they occur. One tool that allows in vivo
monitoring of developmental changes in the neurochemical
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Abstract
The neurochemical profile of the cortex develops in a region
and time specific manner, which can be distorted by psychi-
atric and other neurological pathologies. Pre-clinical studies
often involve experimental mouse models. In this study, we
determined the neurochemical profile of C57BL/6 mice in a
longitudinal study design to provide a reference frame for the
normal developing mouse cortex. Using in vivo proton NMR
spectroscopy at 14 T, we measured the concentrations of 18
metabolites in the anterior and posterior cortex on postnatal
days (P) 10, 20, 30, 60 and 90. Cortical development was
marked by alterations of highly concentrated metabolites,
such as N-acetylaspartate, glutamate, taurine and creatine.
Regional specificity was represented by early variations in the
concentration of glutamine, aspartate and choline. In adult
animals, regional concentration differences were found for
N-acetylaspartate, creatine and myo-inositol. In this study,
animals were exposed to recurrent isoflurane anaesthesia.
Additional experiments showed that the latter was devoid of
major effects on behaviour or cortical neurochemical profile. In
conclusion, the high sensitivity and reproducibility of the
measurements achieved at 14 T allowed us to identify
developmental variations of cortical areas within the mouse
cortex.
Keywords: anaesthesia, cerebral cortex, development,
metabolism, NMR spectroscopy.
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proﬁle is NMR spectroscopy. As such, it is particularly useful
for longitudinal study designs to observe metabolite changes
in the same subjects over time. Basic research aiming at
understanding pathologies of development is predominantly
conducted in animal models. This is mainly the result of
great advances in genetic engineering which allow us to
modify disease associated genes. The purpose of the present
study was to provide a comprehensive account of the
neurochemical proﬁle in the developing mouse cortex using
an in vivo non-invasive longitudinal study design. Although
previous NMR studies have addressed metabolic modiﬁca-
tions in the developing mouse brain (Larvaron et al. 2006;
Weiss et al. 2009), a very limited number of metabolites was
investigated, namely N-acetylaspartate (NAA), taurine (Tau),
total creatine (Cr) and total glutamate plus glutamine. In
addition, only the study by Weiss et al. (2009) employed a
true longitudinal design scanning the same animals repeat-
edly. With 1H NMR spectroscopy at 14.1 T, we evaluated
concentration changes of 18 metabolites at ﬁve developmen-
tal stages – postnatal days (P) 10, 20, 30, 60 and 90 – for
volumes in the anterior and posterior cortex.
This study design incorporated recurrent scans of the same
animals, and thus required recurrent episodes of anaesthesia.
To our knowledge, no study has yet investigated whether
recurrent anaesthesia induces changes in mouse brain
metabolism. Thus, to ensure an unbiased interpretation of
our results, we conducted a control experiment in which we
exposed animals to recurrent anaesthesia at the same
developmental time points as mentioned above. Subse-
quently, we investigated whether recurrent anaesthesia
affected the normal behaviour of the animals or the
neurochemical proﬁle.
We found that recurrent anaesthesia during mouse
development has no adverse effect on behaviour and does
not cause major changes to the neurochemical proﬁle in the
adult animal. Our experiments show moreover that mouse
cortical development is marked by strong alteration of
highly concentrated metabolites such as NAA, Glu, Tau or
Cr and by early regional variations in the concentration of
Gln and aspartate (Asp) before P20, and choline between
P20 and P60. In adult animals, anterior and posterior cortical
areas were marked by differences in NAA, Cr and myo-
inositol (Ins). These results expand our knowledge of
normal mouse brain development and as such provide a
valuable basis for the study of developmental defects in the
cortex of a plethora of available mouse models of disorders
affecting the CNS.
Materials and methods
Animals
All experiments were conducted under approval of the local ethics
committee. For all experiments, we used C57BL/6 mice that were
born in the local animal facility. The neurochemical proﬁle of
anterior and posterior cortical regions was determined in 18 mice
(ﬁve males and 13 females) at postnatal days (P) 10, 20, 30, 60 and
90, under anaesthesia of 1–1.5% isoﬂurane in oxygen gas.
As in vivo NMR scanning of animals at different stages of
development required recurrent anaesthesia, we determined whether
multiple isoﬂurane anaesthesia sessions during development might
affect the cortical neurochemical proﬁle of the adult mice. For this
purpose, a second cohort of mice (10 males and nine females) was
anaesthetized at P10, P20, P30 and P60 with 2% isoﬂurane (in
oxygen) for 90 min, the temperature being maintained at 37C.
Control mice (nine males and eight females) were not anaesthetized
but were separated from the mother for the same period and
maintained under identical temperature and housing conditions. The
neurochemical proﬁle was determined at P90. The mice were
furthermore subjected to a comprehensive battery of behavioural
tasks to investigate whether recurrent anaesthesia interferes with
basic motor function, exploratory activity, anxiety-like behaviour,
mood and learning capacity.
Behavioural testing
To test whether recurrent anaesthesia during postnatal development
has adverse effects on the animals’ general health status and
functioning, we conducted a number of standardized behavioural
tests between P70 and P85. The tests were conducted in the same
order as they are described.
Grip strength test
With both forepaws each animal was placed onto a grip-strength
meter (Columbus Instruments, Columbus, OH, USA). The exper-
imenter gently pulled the mouse backwards by holding it at its tail.
The device measured the peak force exerted by the action of the
animal while gripping the sensor bar. For analysis, we used the
maximum force the animal exerted at the moment of bar release.
The grip strength for each animal was determined as the average of
three successive trials.
Hanging wire test
With their forepaws, animals were individually placed onto a metal
wire that was horizontally suspended between two wooden blocks at
an elevation of 15 cm. The animal had then to move along the wire
(a distance of 30 cm) to escape onto one of the wooden blocks.
Latency to escape was recorded.
Rota-rod test
Four animals at a time were placed onto an automated rota-rod (Ugo
Basile, Comerio, Italy). For 2 min, animals were allowed to
habituate to walking on the rod at slow speed. Following the ﬁrst
2 min, the rod accelerated linearly. Latency to fall was recorded.
Open ﬁeld test
Each animal was placed into the centre of a white non-translucent
rectangular Plexiglas open ﬁeld arena of 60 cm · 40 cm (20 cm
high) and exploration behaviour was monitored for 20 min. For the
purpose of data analysis, the arena was virtually divided into centre
and surround region. Locomotor velocity, distance and time spent
within the centre were recorded with automated tracking software
(Ethovision, Noldus, the Netherlands).
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Elevated plus maze
The maze consisted of white Plexiglas runways (each 30 cm long
and 5 cm broad) arranged in form of a plus at an elevation of 65 cm
above the ﬂoor. Two opposing runways were protected by black
Plexiglas side walls (10 cm high; closed arms), the other arms
contained no walls (open arms). All four arms were joined by a
center platform (5 cm · 5 cm). Animals were individually placed
into the center of the maze facing an open arm and behaviour was
monitored for 10 minutes with Ethovision tracking software.
Latency to enter an open arm, entry frequency and time spent in
the open and closed arms were recorded. An arm entry was recorded
when the whole body (tail excluded) of the animal had entered a
zone.
Y-maze spontaneous alternation
Based on rodents’ natural preference for novelty, mice tend to
explore the arms of a Y-maze successively resulting in an alternation
pattern, which depends on intact spatial working memory. The maze
consisted of three translucent equidistant Plexiglas tunnel arms
(30 cm long, 5 cm wide and 7 cm high) with a sliding door at the
distal end of each arm. Each animal was released at the distal end of
one arm and behaviour was observed for 8 min. Start arms were
randomized between animals and groups. All sessions were
videotaped. The sequence of arm entries and total number of arm
visits, were scored manually. An alternation was deﬁned as three
successive entries into the three separate arms (i.e. ABC, ACB,
BAC, BCA, CAB, or CBA). The per cent alternation was calculated
by multiplying the number of alternations with 100, divided by the
total number of possible alternations (i.e. total number of arm entries
minus 2).
Forced swim test
Animals were individually placed into a transparent Plexiglas
cylinder (inner diameter: 18 cm; height: 25 cm) ﬁlled with water
(25C) to a height of 15 cm. Swimming behaviour was monitored
with a camera and Ethovision tracking software for 5 min. Swim
velocity and distance as well as latency to ﬂoat were recorded.
Floating was deﬁned as a complete absence of movements of all
four paws.
Spatial and object recognition memory
We used an adapted version of the object exploration paradigm
originally described by Buhot and Naı¨li (1995). The test apparatus
was a grey non-translucent square Plexiglas arena (in cm:
50 · 50 · 30). The walls contained a pattern of white stripes that
was interrupted by an area (10 cm wide, 30 cm high) of white
circles on only one wall, which served as internal spatial cue. The
test consisted of one habituation and six test sessions. Each session
lasted 8 min. Between sessions, animals were placed into a holding
cage with access to food and water. Intersession intervals lasted
5 min before familiarization sessions and 15 min before memory
test sessions. Following the habituation period, three dissimilar
objects were secured at pre-determined positions within the arena.
Test sessions 1, 2 and 3 served as familiarization sessions, during
which all objects remained at the same positions, and animals could
establish a stable memory of the objects and their particular spatial
arrangement. After the third familiarization session, one object was
displaced to a new position. Test session 4 evaluated spatial memory
(i.e. whether the animal recognized the position change and
displayed an exploratory preference for the displaced object).
Subsequently, animals were familiarized to the novel spatial
arrangement in one session (test session 5). Following that, one
object that had previously remained in its original position was
replaced by an unfamiliar yet un-encountered object to test object
recognition memory in session 6. Animals that formed a stable
representation of previously present objects, should now preferen-
tially explore the novel object. Test sessions 1, 3, 4 and 6 were video
recorded and the number of object contacts was scored.
NMR spectroscopy
Spontaneously breathing mice under isoﬂurane anaesthesia (1.0–
1.5% in oxygen gas) were ﬁxed in a custom-made holder with foam
cushion for head immobilization (at P10, P20 and P30) or in a
mouse holder with a bite bar and two ear inserts (RAPID
Biomedical, Rimpar, Germany; at P60 and P90). Body temperature
was maintained at 37C by warm water circulation. The duration of
each NMR scanning session was restricted to 100 min maximum.
All experiments were carried out in a horizontal 14.1 T/26 cm
magnet (Varian/Magnex Scientiﬁc, Abingdon, UK), with a 12-cm
inner-diameter gradient (400 mT/m in 200 ms, minimized eddy
currents), interfaced with a DirectDrive console (Varian Inc., Palo
Alto, CA, USA). Radio frequency transmission and reception was
achieved with a home-built quadrature surface coil composed of two
geometrically decoupled single-turn loops of 8 mm inner diameter
resonating at 600 MHz. The mouse brain was positioned in the
isocentre of the magnet and located with fast-spin-echo images with
repetition time of 4 s, echo time of 52 ms and echo train length of 8.
Field homogeneity in the region of interest was achieved with
FAST(EST)MAP (Gruetter 1993; Gruetter and Tka´cˇ 2000). Volumes
of interest (VOI) were placed in anterior and posterior regions of the
cortex of the C57BL/6 mice (respectively, at 0.62 and )2.0 mm
relative to Bregma, according to the mouse brain atlas by Franklin
and Paxinos 2008). As shown in Fig. 1, the anterior VOI was placed
above the frontal part of the ventricles whyle the posterior VOI was
above the hippocampal formation. The size and position of the VOIs
were adjusted proportionally to the brain size of the mice at different
ages to include similar tissue composition (see illustration in Fig. 1).
Thus, the total volume of the VOIs ranged from 2.5 to 3.8 lL
(Table 1). 1H NMR spectra were acquired using SPECIAL
(Mlyna´rik et al. 2006) with echo time of 2.8 ms, repetition time
of 4 s and typically with 480 scans.
Metabolite concentrations were determined using the linear
combination analysis method LCModel (Provencher 1993), includ-
ing a macromolecule spectrum in the database, as in previous studies
(e.g. Mlyna´rik et al. 2006). The unsuppressed water signal
measured from the same VOI was used as an internal reference
for the quantiﬁcation of metabolites, using corrections for water
content variations during development. Namely, water content was
assumed 86.5% at P10 and 80.0% from P20 onwards (e.g. Tka´cˇ
et al. 2003; Larvaron et al. 2006). The following 20 metabolites
were included in the LCModel analysis: alanine (Ala), ascor-
bate (Asc), Asp, Cr, GABA, Gln, Glu, GSH, glycine,
glycerophosphocholine, glucose (Glc), lactate (Lac), Ins, NAA,
N-acetylaspartylglutamate (NAAG), phosphoethanolamine (PE),
phosphocholine (PCho), phosphocreatine (PCr), scyllo-inositol,
Tau. The Crame´r-Rao lower bound (CRLB) was provided by
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LCModel as a measure of the reliability of the apparent metabolite
concentration quantiﬁcation. At most of the measured ages, the
present analysis was not able to reliably discern PCho from
glycerophosphocholine. Therefore their sum was quantiﬁed as
choline-containing compounds (GPC + PCho). As the relative
content of Cr and PCr may depend on the energy status of the
tissue, the total Cr concentration (Cr + PCr) was reported as a
constitutive metabolic pool of the tissue.
Statistical analysis
Results are presented as mean ± SEM of n mice, unless otherwise
mentioned. The concentration of each metabolite was analysed with
a two-way ANOVA followed by the Bonferroni’s multi-comparison
post-test. Behavioural data were analysed with univariate ANOVA and
signiﬁcant interactions were followed up with independent sample
t-tests. Signiﬁcance was considered for p < 0.05.
Fig. 1 Representative in vivo 1H NMR spectra at 14.1 T in the mouse
cortex during development and in adult. Spectra were acquired from
volumes of 2.5–3.5 lL localized in anterior and posterior regions of the
mouse cortex, as indicated in the respective T2-weighed images,
using SPECIAL with TE = 2.8 ms, TR = 4s and typically 480 scans.
Free induction decays were weighted with a shifted gausian function
(gf = 0.12, gfs = 0.05) before Fourier transformation. The signals
assigned in the spectra refer to the following metabolites: alanine
(Ala), ascorbate (Asc), aspartate (Asp), creatine (Cr), phosphocreatine
(PCr), c-aminobutyrate (GABA), glycerophosphocholine (GPC), glu-
tamate (Glu) glutamine (Gln), N-acetylaspartate (NAA), N-aceyl-
aspartylglutamate (NAAG), lactate (Lac), myo-inositol (Ins),
phosphocholine (PCho), phosphoethanolamine (PE), taurine (Tau).
Table 1 Dimensions of the VOIs in anterior and posterior areas of the
cortex was changed according to the brain size at different postnatal
ages
Height
(mm)
Width
(mm)
Length
(mm)
P10 Anterior 0.8 3.5 1.0
Posterior 0.7
P20 Anterior 0.8 3.8 1.0
Posterior 0.7
P30 Anterior 0.8 4.0 1.0
Posterior 0.7
P60/P90 Anterior 0.8 4.0 1.2
Posterior 0.7
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Results
Effect of recurrent isoflurane anaesthesia on behaviour
and neurochemical profile
In the present study, recurrent anaesthesia periods were
required for in vivo determination of the cortical neurochem-
ical proﬁle evolution by 1H NMR spectroscopy. Therefore,
we ﬁrst tested whether isoﬂurane anaesthesia during devel-
opment has an effect on behaviour and the cortical neuro-
chemical proﬁle of adult mice.
Table 2 summarizes the behavioural data. Mice submitted
to recurrent anaesthesia periods show similar performance as
control mice in all behavioural tasks. We found a signiﬁcant
gender · group interaction for the latency to escape the
hanging wire (p = 0.008). Follow-up t-tests for gender
speciﬁc group differences were non-signiﬁcant (p = 0.061
for males; p = 0.126 for females) suggesting that anesthe-
tized and control animals of the same sex had a similarly
good capacity to escape the hanging wire. This is in line with
the fact that mice exposed to recurrent anaesthesia perform
like control mice in all other measurements for general motor
behaviour. Similarly, we found a signiﬁcant gender x group
interaction (p = 0.047) for the latency to ﬂoat in the Porsolt
swim test. Again, post hoc t-tests tests revealed no gender-
speciﬁc impairments (p = 0.077 for males; p = 0.246 for
females). Thus, overall our results suggest that repeated
isoﬂurane anaesthesia during development does not affect
adult mouse behaviour.
From the 1H NMR spectra of recurrently anaesthetized and
control mice (P90), we were able to estimate the concentra-
tion of 20 metabolites, in anterior and posterior regions of the
cortex, with average CRLBs of 15 ± 4%. As the neuro-
chemical proﬁle in both cortical regions was similar in male
and female mice, the data of both genders were combined.
Table 3 shows that the neurochemical proﬁle of both the
anterior and posterior cortex was not generally affected by
recurrent anaesthesia periods during development. Only Tau
levels were consistently increased in posterior and anterior
cortical areas by 15 ± 3% (p < 0.01) and 8 ± 3% (p < 0.05)
respectively, in comparison to the unanaesthetized group.
Glu content was signiﬁcantly increased by recurrent anaes-
thesia in the posterior cortex (+ 9 ± 2%, p < 0.05).
Development of the neurochemical profile
Examples of typical in vivo 1H NMR spectra of the
developing mouse anterior and posterior cortical areas are
shown in Fig. 1. A ﬁrst visual examination of the spectra
indicates that major metabolite signals were similar in
anterior and posterior cortex. However, development over
time had a great impact on the majority of metabolites.
Table 2 Behaviour in adult animals after recurrent isuflorane anaesthesia. Data are presented as mean ± SEM. Performance on the rotarod is
evaluated as the latency to fall and is shown in seconds. Other measurements in seconds are: Escape latency from a hanging wire, time spent in
the open field center and the latency to float in the forced swim test. Distance travelled in the open field and swim distance are represented in
meters. Data were analysed with univariate ANOVA. Significant interactions were followed up with independent sample t-tests. Symbols: §§significant
gender · group interaction, p < 0.01. Note: there were no significant gender-specific group effects
Males Females
Control (n = 8)
Recurrent anaesthesia
(n = 10) Control (n = 5)
Recurrent anaesthesia
(n = 9)
General motor behaviour
Forepaw grip strength 0.217 ± 0.02 0.226 ± 0.02 0.213 ± 0.01 0.207 ± 0.02
Running on the rotarod 154.0 ± 21.8 133.5 ± 17.1 162.3 ± 14.5 195.2 ± 47.1
Escape from hanging wire 0.28 ± 0.05 0.16 ± 0.02§§ 0.15 ± 0.02 0.24 ± 0.05
Open field exploratory activity
Total distance 81.7 ± 2.8 92.1 ± 5.2 104.6 ± 4.7 93.9 ± 5.3
Time in center 163.3 ± 25.4 166.4 ± 14.1 194.7 ± 12.0 130.3 ± 10.7
Elevated plus maze
Open arm entries 2.3 ± 0.5 1.8 ± 0.6 2.6 ± 0.6 2.8 ± 1.1
Forced swim test
Total swim distance 11.1 ± 0.6 11.5 ± 0.6 10.5 ± 0.8 11.7 ± 1.1
Latency to float 109.0 ± 6.1 89.9 ± 8.2§ 71.8 ± 14.8 92.8 ± 11.6
Spatial working memory
Y-maze alternation ratio 0.60 ± 0.03 0.52 ± 0.02 0.53 ± 0.04 0.53 ± 0.05
Spatial memory
Object exploration ratio 0.65 ± 0.02 0.63 ± 0.03 0.67 ± 0.03 0.63 ± 0.02
Object memory
Object exploration ratio 0.68 ± 0.02 0.67 ± 0.02 0.71 ± 0.02 0.68 ± 0.04
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Clearly visible are gradual increases of the signals for Glu,
NAA, Ins, Asp, total Cr and total choline. Simultaneously,
signals corresponding to Tau, Asc and PE decreased with
postnatal age.
The spectra allowed determining a neurochemical proﬁle
of 18 metabolites which were quantiﬁed with CRLB
generally below 25%. Exceptionally, some metabolites that
occur at low concentration in the cortex were quantiﬁed with
CRLB above 25% at some postnatal ages, like Glc and
NAAG, and Asp. The spectrum of scyllo-inositol was
included in the linear combination analysis but since it was
not detected in a large part of the analysed spectra, its
concentration was excluded from the reported neurochemical
proﬁle during development.
Figures 2, 3 and 4 show the evolution of the concentration
of each metabolite for both cortical areas. The neurochemical
proﬁle of the mouse cortex changed gradually from P10 to
P90, with the most prominent modiﬁcations occurring
between P10 and P20. Exception was GABA (Fig. 2) that
remained nearly constant over time. While the cortical
concentrations of NAA, Asp, Glu, Gln, Ins, Cr, choline
compounds and glutathione increased with age, the content
of glycine, NAAG, Tau, PE and Asc decreased in the
developing mouse cortex (p < 0.01 for each of the metab-
olites, n = 12). As shown in Fig. 4, Glc concentration in the
cortex increased with age (p < 0.05, n = 12); however, its
glycolytic products displayed a different trend. Although Ala
concentration reduced in the developing mouse cortex
(p < 0.001, n = 12), Lac content was variable between
2.0 ± 0.2 and 1.3 ± 0.1 lg/mol with a maximum concentra-
tion at P60 (p < 0.05, n = 12).
The determination of absolute metabolite concentrations
and respective analysis of variance revealed that the devel-
opment of the neurochemical proﬁle was distinct in the two
analysed cortical areas. The metabolites that developed
differently in anterior and posterior cortex include NAA,
Asp, Gln, Ins, Cr and choline-containing compounds. More
speciﬁcally, the concentrations of NAA, Ins and total Cr were
similar in both regions from P10 to P60, but increased to a
greater extent in the posterior than the anterior cortex at P90
(p < 0.01 for the three metabolites, n = 12). Gln concentra-
tions were signiﬁcantly higher in the posterior as compared
to the anterior cortex at early development (p < 0.001,
n = 12). In addition, the posterior cortex displayed lower
Table 3 Adult neurochemical profile in the anterior and posterior cortex measured by in vivo 1H NMR spectroscopy is not greatly affected by
repeated isoflurame anaesthesia (2% in O2 gas) for 90 min at P10, P20, P30, P60, and during scan at P90. Concentrations are shown as
mean ± SD of nine male and eight female mice in the control group, and 10 male and nine female mice on the recurrent anaesthesia group. Data
were analysed with the two-way ANOVA followed by the Bonferroni multi-comparison test (*p < 0.05, **p < 0.01 compared with unanaesthetized
group)
Anterior cortex Posterior cortex
Control
Recurrent
anaesthesia Control
Recurrent
anaesthesia
Alanine 0.90 ± 0.36 1.17 ± 0.57 0.88 ± 0.37 1.09 ± 0.39
Aspartate 1.84 ± 0.86 2.29 ± 0.48 1.85 ± 0.70 2.29 ± 0.87
PCho 0.48 ± 0.37 0.53 ± 0.35 0.56 ± 0.41 0.64 ± 0.30
Creatine 4.01 ± 0.57 3.85 ± 0.61 4.23 ± 0.74 4.50 ± 0.61
Phosphocreatine 3.59 ± 0.57 4.23 ± 0.70 3.94 ± 0.41 4.26 ± 0.83
GABA 1.80 ± 0.49 1.68 ± 0.26 1.99 ± 0.66 1.83 ± 0.26
Glutamine 3.57 ± 1.02 3.33 ± 0.83 3.85 ± 1.15 3.56 ± 0.91
Glutamate 10.4 ± 1.5 11.0 ± 0.8 10.3 ± 1.2 11.2 ± 0.9*
Glutathione 1.24 ± 0.41 1.36 ± 0.30 1.18 ± 0.41 1.19 ± 0.30
Glycine 0.92 ± 0.49 1.05 ± 0.44 1.53 ± 0.70 1.22 ± 0.44
myo-inositol 4.36 ± 0.86 4.51 ± 0.83 4.84 ± 0.90 4.62 ± 0.57
Lactate 1.69 ± 0.90 1.66 ± 0.87 2.05 ± 0.94 1.61 ± 0.87
N-Acetylaspartate 8.71 ± 0.98 8.54 ± 0.61 9.56 ± 0.98 9.73 ± 0.83
scyllo-inositol 0.18 ± 0.15 0.21 ± 0.73 0.18 ± 0.12 0.18 ± 0.09
Taurine 10.2 ± 1.8 11.0 ± 1.2* 8.90 ± 1.64 10.2 ± 1.3**
Ascorbate 1.49 ± 0.90 2.12 ± 1.04 1.21 ± 0.82 1.55 ± 0.83
Glucose 1.76 ± 1.68 1.60 ± 1.04 2.01 ± 1.35 1.83 ± 1.04
NAAG 0.82 ± 0.41 0.79 ± 0.22 0.85 ± 0.37 0.64 ± 0.26
GPC 0.70 ± 0.37 0.83 ± 0.35 0.52 ± 0.29 0.48 ± 0.30
Phosphoethanolamine 1.83 ± 0.62 1.94 ± 0.57 1.28 ± 0.62 1.72 ± 0.70
GPC + Pcho 1.11 ± 0.21 1.23 ± 0.22 1.03 ± 0.29 1.10 ± 0.22
GABA, c-aminobutyrate; GPC, glycerophosphocholine; NAAG, N-aceylaspartylglutamate; Pcho, phosphocholine.
 2010 The Authors
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concentrations of choline-containing compounds than the
anterior cortex at P30 and P60 (p < 0.05, n = 12).
Discussion
Recurrent anaesthesia
This is the ﬁrst report of an extended neurochemical proﬁle
of 18 metabolites determined in the mouse cortex during
development until adult age. The neurochemical proﬁle was
determined in a non-invasive manner using 1H NMR
spectroscopy under isoﬂurane anaesthesia. Previous studies
have shown that isoﬂurane exposure during early develop-
ment can lead to dose-dependent abnormal neuronal devel-
opment, abnormal synaptic plasticity, neurodegeneration
(reviewed in Wang and Slikker 2008), and behavioural and
cognitive impairments (Rothstein et al. 2008; Valentim et al.
2008). Here, we demonstrate that recurrent 2% isoﬂurane
anaesthesia during mouse development leaves cortical func-
tion intact as suggested by the generally unaltered neuro-
chemical proﬁle and normal behavioural performance. Tau
was signiﬁcantly changed in both anterior and posterior
cortex following anaesthesia. It is known that isoﬂurane can
modulate Tau release and tissue content (e.g. Ritz et al.
2006). The mechanism, however, remains unclear. We also
observed a minor, although signiﬁcant, elevation of Glu
levels in the posterior cortex. Previous studies have shown
that isoﬂurane can exert effects on the glutamatergic synapse
by reducing pre-synaptic Glu release and increasing its
uptake from the synaptic cleft (e.g. Larsen and Langmoen
Fig. 2 Concentration of metabolites in the anterior (open symbols)
and posterior (filled symbols) cortical areas of the developing mouse.
Data are shown as mean ± SEM of 18 mice (five males and 13 fe-
males) and compared with two-way ANOVA. With exception of GABA,
the concentrations of the metabolites in the figure were modified
during development (###p < 0.001); concentrations of glutamate, glu-
tamine, NAA and aspartate develop differently in each cortical area
(§p < 0.05, §§§p < 0.001).
Fig. 3 Concentration of metabolites in the anterior (open symbols)
and posterior (filled symbols) cortical areas of the developing mouse.
Total creatine represents the sum of creatine and phosphocreatine
concentrations. As at most ages the LCModel analysis failed to dis-
tinguish phosphocholine and glycerophosphocholine resonances, their
sum is here displayed as the total choline-containing compounds. Data
are shown as mean ± SEM of 18 mice (five males and 13 females)
and compared with two-way ANOVA. The concentrations of all the
metabolites in the figure were modified during development
###p < 0.001); the development of myo-inositol, creatine (and total
creatine) and choline compounds is different the anterior and posterior
cortex (§p < 0.05, §§p < 0.01, §§§p < 0.001).
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1998). However, with our protocol, Glu alteration caused by
recurrent anaesthesia was below 10% and was only signif-
icant in one of the measured cortical areas. Recently, it was
shown that isoﬂurane anaesthesia during development may
lead to neuronal loss and reduced neurogenesis in the
hippocampus, propitiating memory impairment (Zhu et al.
2010). In this study by Zhu et al. (2010), like others, mice
were submitted to anaesthesia sessions for four consecutive
days, while in this study sessions occurred with intervals of
10 days. Interestingly, although not signiﬁcant, PCr/Cr
tended to increase in recurrently anaesthetized mice, sup-
porting the lack of metabolic deterioration when compared to
controls. In conclusion, recurrent isoﬂurane exposure during
development might have small effects on Tau and Glu
concentrations, which were detected as a result of the high
reproducibility of the methodology used. All other metabo-
lites remained unaltered, indicating that longitudinal study
designs with C57BL/6 mice involving recurrent isoﬂurane
anaesthesia during development can provide valuable data
generally devoid of unspeciﬁc effects introduced by the
anaesthesia procedure itself.
Developmental neurochemical profile of the mouse cortex
Two previous spectroscopy studies of mouse brain develop-
ment investigated the neurochemical proﬁle of the thalamus,
the olfactory bulb, cerebellum (Larvaron et al. 2006),
midbrain, and the basal ganglia (Weiss et al. 2009). This is
the ﬁrst study that evaluates the developing neurochemical
proﬁle of the mouse cortex. Our ﬁndings are in general
agreement with results in rat cortex obtained in vivo (Tka´cˇ
et al. 2003) or from brain extracts (e.g. Burri et al. 1990).
The concentrations of most brain metabolites comprising the
neurochemical proﬁle changed with development reﬂecting
the structural and functional evolution inherent to the
differentiation of cortical networks.
Neurotransmitter metabolism
Amino acid neurotransmitters are the most abundant trans-
mitters in the CNS playing an important role in the wiring of
neuronal networks and organizing brain cytoarchitecture
during development. Glu and Asp are the dominant excit-
atory amino acids. Our spectra revealed that the concentra-
tions of both increased steadily from P10 to P60 and reached
a steady state thereafter, as previously demonstrated in
cortical extracts (Benı´tez-Diaz et al. 2003). The fast early
concentration rise especially of Glu closely parallels the time
course of glutamatergic synaptogenesis and marks a period
of ongoing reﬁnement of cortical circuitry. As glutamatergic
synapses develop and mature, energy demand rises. Gluta-
matergic neuronal activity requires 60–70% of total Glc
(Chowdhury et al. 2007). Thus, this early period is also
associated with a major step in the maturation of energy
metabolism, demonstrated by the concomitant increase in
Glc levels.
Glutamine concentrations rise within the ﬁrst weeks of
life, similar to those of Glu. The same pattern has been
observed in the developing rat cortex (Tka´cˇ et al. 2003). It is
expected that Glu and Gln concentrations develop similarly
as both are functionally coupled through the Glu–Gln cycle
(for review see e.g. Zwingmann and Butterworth 2005).
GABA concentrations remained stable throughout the
investigated period. This is in accordance with previous
reports in the rat brain (e.g. Tka´cˇ et al. 2003). Changes in
GABA concentrations would be expected before P10, at the
time of GABAergic inhibitory synapse formation (Anderson
et al. 1995) and the increment of cortical GABA-binding
sites (Skerritt and Johnston 1982).
NAAG is a highly abundant neuromodulatory peptide in
the brain that is expressed in neuronal terminals (Shave et al.
2001) and to a lesser extend may also be expressed in glial
cells (Cassidy and Neale 1993). It acts on pre-synaptic
metabotropic Glu receptors (mGluR2/3) to down-regulate
neurotransmitter release via negative feedback (Zhao et al.
2001) and it was shown to act on NMDA either as direct
agonist (e.g. Westbrook et al. 1986) or antagonist (e.g.
Burlina et al. 1994). We found that NAAG levels are highest
at P10 and decline thereafter to reach a stable plateau at adult
age. This exactly mimics early results obtained with tissue
extracts (Koller and Coyle 1984), reporting a substantial
Fig. 4 Concentration of metabolites in the anterior (open symbols)
and posterior (filled symbols) cortical areas of the developing mouse.
Data are shown as mean ± SEM of 18 mice (five males and 13 fe-
males) and compared with two-way ANOVA. The concentrations of
glucose, lactate alanine glutathione and ascorbate were modified
during development (#p < 0.05, ###p < 0.001); the development of all
the metabolites presented in the figure was not significantly different
between anterior and posterior cortical areas.
 2010 The Authors
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NAAG increase from mid-gestation to P8 and followed by a
steady decline.
Glycine has a dual role as inhibitory neurotransmitter,
activating glycine receptors, and as co-agonist for Glu
excitatory transmission through NMDA receptors (Betz and
Laube 2006). We observed highest glycine concentrations
at P10. Others have reported that the rate of glycine
synthesis peaks around 10–15 days after birth (Lahoya
et al. 1980; Benı´tez-Diaz et al. 2003) and that likewise,
during this period, glycine receptors undergo a major
switch of the relative expression of glycinergic subunits
(Lynch 2004). It is interesting to note that the increase of
levels of excitatory neurotransmitters, Glu and Asp
(NMDA receptor agonists), is paralleled by a reduction
in the concentration of its modulator NAAG and co-agonist
glycine.
Among other functions, Tau is also a neuromodulator
(Gupta et al. 2009). Tau released from glial cells may be an
important endogenous ligand for the glycine receptor during
the period of cortical synaptogenesis (Flint et al. 1998).
Accordingly, like glycine, Tau concentration in the cortex
was maximal at P10 and decreased to adult age.
Myelination/cell proliferation/membrane metabolism
Phosphorylethanolamine (PE) is precursor for phosphatidyl-
ethanolamine, which is a major phospholipid in the brain
(Quarles et al. 2006). PE concentration decreased during
mouse cortical development, consistent with observations in
rats and humans, parallel to the progression of myelination
(Blu¨ml et al. 1999; Rao et al. 2003). Developmental increase
of NAA content in cortical regions may be associated with its
role in lipid and myelin synthesis (D’Adamo and Yatsu 1966;
Burri et al. 1991). In fact, although NAA is mainly
synthesized and stored in neurons (e.g. Baslow 2003), its
deacetylation is required by oligodendrocytes for myelin
synthesis (Kirmani et al. 2002). The signiﬁcant reduction in
PE and increase in NAA concentrations in the cerebral cortex
from P20 onwards may reﬂect the start of deposition of
myelin that is very rapid between P14 and P30 yet continues
afterwards (Costantino-Ceccarini and Morell 1972; Muse
et al. 2001).
We observed an increase in choline concentration between
P20 and P60 in both the anterior and posterior cortex.
Previous in vivo or in vitro spectroscopy studies with mice
have disregarded cortical areas (e.g. Yao et al. 1999;
Larvaron et al. 2006; Weiss et al. 2009) and, therefore, we
could not ﬁnd a comparison for these data. Interestingly, in
the developing rat cortex, choline concentration did not
change substantially during development (Tka´cˇ et al. 2003).
Choline compounds are essential for membrane lipid
synthesis and act as precursor for the biosynthesis of the
neurotransmitter acetylcholine. Specially during embryonic
brain development, choline availability seems crucial for the
onset of GABAergic neuronal differentiation (Albright et al.
2003) and progenitor cell proliferation and apoptosis in
mouse brain (Craciunescu et al. 2003).
Energy metabolism
Depending on its physiological state and maturity, the brain
utilizes different energy substrates including Glc, ketone
bodies and Lac (e.g. Lust et al. 2003). We report very low
levels of cortical Glc at P10 and a gradual increase thereafter,
suggesting that energy metabolism of the immature neonatal
rodent brain may rely to a large extend on energy sources
different from Glc. In fact, in the brain of suckling rodents,
ketone bodies can represent up to 70% of the total energy
substrate pool (Nehlig 2004). Rheims et al. (2009) have
shown that, during early postnatal development (P3–P19),
ketone body availability modulates GABA signalling and
efﬁciently controls the excitability of neonatal cortical
neurons. Cortical development was characterized by increas-
ing Glc concentrations which result from larger increase in
the density of Glc transporters (e.g. Vannucci et al. 1994)
rather than the augment in the cerebral Glc consumption rate
(Nehlig 2004).
We found that Lac concentrations are relatively unaltered
during early development and increase at adult age. Data
from developing rats are controversial. Tka´cˇ et al. (2003)
failed to ﬁnd changes in Lac concentration during rat cortical
development, whereas Lust et al. (2003) found high lacate in
neonate rats and a strong decrease in adults. The develop-
mental expression pattern of Lac transporters within the brain
is complex. Some Lac transporters (e.g. monocarboxylate
transporter 1) are highly expressed during early postnatal
development and less so in the adult brain. Other transporters
(e.g. monocarboxylate transporter 2) increase with neuronal
maturation and synaptogenesis (e.g. reviewed in Castro et al.
2009). The ﬂuctuation in Lac levels found in the present
study may, therefore, be a reﬂection of this complexity. The
developmental time course of Lac utilization remains
unclear.
Recent studies suggest that Lac generated and released by
astrocytes serves as energy substrate for neurons, especially
during synaptic activity (Pellerin and Magistretti 1994), and
that Asc plays a role in this process (Castro et al. 2009).
Here, we found that cortical Asc concentration decreases
from P10 to adult age, therefore suggesting that Asc-induced
Glc transport inhibition and Lac transport stimulation may be
higher in early developmental stages than in adulthood. This
corroborates the preferential use of other substrates rather
than Glc by the developing brain (Lust et al. 2003).
Alanine is an amino acid with close links to metabolic
pathways such as glycolysis, tricarboxylic acid cycle and
protein synthesis. Like for Lac, with which it is in
equilibrium although pyruvate, conﬂicting observations were
reported for Ala concentrations in the developing rat brain
(Bayer and McMurray 1967; Burri et al. 1990; Tka´cˇ et al.
2003). We found that cortical Ala content decreases during
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development, as previously shown in mouse brain extracts
(Yao et al. 1999), reﬂecting the high protein turnover in the
developing brain as result of cell proliferation and tissue
expansion. These events require high availability of stored
energy, typiﬁed in the larger concentration of PCr relative to
Cr at early developmental ages. Cr that was found to increase
in the cortex during development follows the modiﬁcation in
brain Cr kinase activity (Manos et al. 1991), which is a
critical component in maintaining cellular energy homeosta-
sis by buffering brain energy demands.
Finally, it is important to stress that the brain energy status
depends on brain activity and, therefore, on the anaesthesia
used for the NMR study (Lei et al. 2010). Thus, much care
should be taken when comparing the present observations to
other reports found in the literature.
Osmoregulation
Osmolarity regulation in the brain is considered to occur,
among others, via the concentrations of Tau and Ins. Tau is
known to have three main roles in the brain, namely acting as
neuromodulator (discussd above), antioxidant and osmoreg-
ulator (Gupta et al. 2009). Accordingly, it is one of the most
concentrated metabolites in the cortical tissue, decreasing
from 17 mM at P10 to 10 mM in adult mice. Similar
observations were reported for other brain regions (Weiss
et al. 2009). Although these in vivo studies did not follow the
mice until adult age, in vitro determination of Tau lead to
similar ﬁndings (Yao et al. 1999). However, to our knowl-
edge this is the ﬁrst determination of Ins concentrations
in vivo during mouse brain development. During develop-
ment, Ins content increased in the mouse cortex, as was
shown to occur in the rat (Tka´cˇ et al. 2003). As osmolyte,
brain Ins increases in compensation to Tau reduction. On the
other hand, this increase of Ins concentration may be related
to the demand for synthesis of inositol-containing phospho-
lipids during synaptogenesis, axonal growth and myelination.
In line with this, Yao et al. (1999) reported increase of
phosphatidylinositol that may be incorporated into lipid
membranes (Quarles et al. 2006) during mouse brain devel-
opment.
Antioxidant defense
Glutathione, a major redox regulator and antioxidant, slightly
increased before P20 and remained unaltered through the
following development similar to reports in rats (Tka´cˇ et al.
2003). Glutathione acts in concert with Asc (vitamin C)
which is a potent antioxidant and enzyme co-factor in the
brain. As such Asc is involved in antioxidant protection, but
also plays a role in myelin formation (Eldridge et al. 1987),
enhancement of synaptic activity (Rebec and Pierce 1994),
regulation of Glc metabolism (Castro et al. 2009) and
protection from excitotoxicity (Qiu et al. 2007). Our spectra
showed high Asc concentrations in young (P10) animals and
a subsequent steady decline until adulthood. In line with this
are observations that young rodents are more prone to
oxidative stress than are mature animals (Lykkesfeldt 2002)
and that the developing rodent brain is particularly suscep-
tible to vitamin C deﬁciency because of rapid growth and
immature antioxidant defence systems (Lykkesfeldt et al.
2007). Indeed, vitamin C deﬁciency in early postnatal life
results in impaired neuronal development and spatial mem-
ory deﬁcits (Tveden-Nyborg et al. 2009). Mice, in contrast to
humans, are able to endogenously synthesize vitamin C.
Thus, one possible explanation for our results is that mice
adapt vitamin C synthesis according to demand, and produce
higher levels during the particularly sensitive early postnatal
period. As the organism and its antioxidant systems mature,
less vitamin C is needed and synthesis is down-regulated.
Also the osmolite Tau that has an antioxidant function was
more concentrated at early development.
Anterior and posterior cortical regions
The ﬁne quality of the spectra in this study revealed
differences in the neurochemical proﬁle of anterior and
posterior regions of the cortex. The anterior VOI covered
parts of the anterior cingulate cortex, primary and secondary
motor cortex as well as primary somato-sensory cortex. The
posterior VOI contained parts of the retrosplenial granular
and dysgranular as well as secondary visual cortices and
associative areas. The time course of maturation is consid-
erably different across diverse cortical areas and generally
parallels the time course of cognitive milestones. Thus,
primary sensory-motor areas mature earliest, followed by
posterior parietal and temporal cortices associated with
spatial attention. Anterior prefrontal areas modulating higher
cognitive functions such as planning mature latest (for
review see Casey et al. 2005). In this study, both the anterior
and the posterior VOIs encompass parts of sensory as well as
higher cognitive areas.
We observed that the concentrations of Gln, Asp, NAA,
Cr, Ins and choline-containing compounds were signiﬁcantly
different in anterior and posterior regions of the mouse
cortex. As discussed above, NAA and Ins are both related to
membrane phospholipid synthesis. Since the posterior cortex
VOI is in the proximity of corpus calosum, which contains
high density of myelinated ﬁbers, the higher concentration of
NAA and Ins may relate to larger phospholipid synthesis in
the posterior compared with anterior cortex of the adult
mouse (see Kirmani et al. 2002). This requires extra energy
and it is of interest to note that Cr concentration was also
increased in that region. Although the concentration of
choline-containing compounds evolved differently between
the two regions, reﬂecting this difference in phospholipid
metabolism, it reached similar levels in the adult mouse. Gln,
mainly present in glia, occurred at higher concentration in
posterior than anterior cortex at P10 and P20 and the
opposite was observed for Asp. This may be related to higher
density of oligodendrocytes in the posterior cortex, being
 2010 The Authors
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responsible for myelin synthesis for the ﬁbers of the adjacent
corpus callosum (see Quarles et al. 2006).
Conclusions
This is the ﬁrst report of in vivo simultaneous quantiﬁcation of
18 metabolites in the developing mouse brain. The reliability
and reproducibility of 1H NMR spectroscopy allowed
detecting signiﬁcant metabolic differences at different time
points corresponding to stages of cortical development. It also
allowed detection of regional differences in the anterior and
posterior cortex that we attribute to different phospholipid
metabolism related to myelin deposition. Moreover, this work
allowed concluding that the anaesthesia protocol here
employed is devoid of adverse effects on the development
of the mouse cortex. As such, high resolution NMR in mice
may qualify as method of choice for in vivo translational
investigations of pre-clinical animal models of human
developmental neurological and psychiatric pathologies.
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